A vial of the Phase 3 Novavax coronavirus vaccine is seen ready for use in the trial at St. George’s University hospital in London Wednesday, Oct. 7, 2020. Novavax Inc. said Thursday Jan. 28, 2021 that its COVID-19 vaccine appears 89% effective based on early findings from a British study and that it also seems to work — though not as well — against new mutated strains of the virus circulating in that country and South Africa. (AP Photo/Alastair Grant)

A vial of the Phase 3 Novavax coronavirus vaccine is seen ready for use in the trial at St. George’s University hospital in London Wednesday, Oct. 7, 2020. Novavax Inc. said Thursday Jan. 28, 2021 that its COVID-19 vaccine appears 89% effective based on early findings from a British study and that it also seems to work — though not as well — against new mutated strains of the virus circulating in that country and South Africa. (AP Photo/Alastair Grant)

Canada signs deal with Novavax to make its COVID-19 vaccine at new Montreal facility

Novavax’s vaccine is likely at least two months away from being approved in Canada

Prime Minister Justin Trudeau is expected to announce today a deal with Novavax to produce doses of its new COVID-19 vaccine at a new National Research Council biomanufacturing facility in Montreal.

More details are expected on making some COVID-19 therapeutic drugs at other facilities in Canada.

The deal could help Trudeau tamp down the political headache caused by Canada’s skeletal vaccine production capacity.

But Novavax’s vaccine is likely at least two months away from being approved in Canada, while the NRC facility is still under construction and designed to produce only about two million doses a month.

Canada has a deal to buy 52 million doses from Novavax after it is approved by Health Canada.

Canada’s inability to produce any COVID-19 vaccines at home has left the country at the mercy of foreign governments, who could at any time slam the doors shut to vaccine exports until their own people are vaccinated.

That risk became ever more real this week as Europe’s new export controls on vaccines take hold, putting at risk Canada’s entire supply of COVID-19 vaccines.

All doses from the currently approved vaccines being produced by Pfizer-BioNTech and Moderna are being made in Europe.

Maryland-based Novavax applied Friday to start the regulatory review process for its experimental vaccine, after announcing a clinical trial in the United Kingdom showed it was more than 89 per cent effective against COVID-19.

The trial in the U.K. showed significant effectiveness against both the original virus behind COVID-19, and the variant known as B. 1.17 that was first identified there. A smaller Phase 2 trial in South Africa showed the vaccine was also effective against a variant that first emerged there, known as B. 1.351.

The Pfizer-BioNTech and Moderna vaccines have shown potential in lab tests against the variants, which are believed to spread more easily and may cause more serious illness. However, the trials that led to those vaccines being approved were completed before the variants had been identified.

More than half the COVID-19 cases identified in Novavax’s British trial were the B. 1.17 variant and 90 per cent of the cases in South Africa were B. 1.351.

Novavax is also in the midst of a big trial in the United States, but a spokeswoman told The Canadian Press safety results are not expected for at least another month.

The federal department of Innovation, Science and Economic Development and the National Research Council have been in talks with all the front-running vaccine makers in the world for months, trying to lure at least one of them to make some of their vaccines at the new facility, which is on track to be finished this summer.

None of those talks have borne any fruit until now.

“I have received positive feedback from some leading vaccine manufacturers in these discussions, and so we are moving full steam ahead to build Canada’s domestic production of vaccines,” said Industry Minister Francois-Phillippe Champagne, in a statement to The Canadian Press.

The National Research Council was even rebuffed in offers to help all leading vaccine makers do research on scaling up their production processes to make the precious doses as fast as possible.

None of those offers was accepted.

Talks to do that with Novavax fell apart at the 11th hour last fall, right before an initial agreement for Canada to buy 52 million doses of Novavax’s vaccine was announced.

READ MORE: Novavax submits vaccine for approval as Ottawa seeks EU reassurances on export rules

An email chain, released to the House of Commons health committee as part of a new batch of documents on Canada’s pandemic response, shows a reference to the agreement was deleted from the memorandum of understanding with Novavax the day before the deal was made public.

The National Research Council was also going to make doses of CanSino Biologic’s vaccine, in a deal that included a $44-million upgrade of the NRC’s Royalmount facility in Montreal.

But Canada’s partnership with CanSino fell apart almost as quickly as it began, when China refused to allow any doses of the vaccine to be exported to Canada for use in a clinical trial here.

The vaccine is made using technology that was developed at the NRC and then licensed to CanSino for use in an Ebola vaccine.

After that deal fell apart, the Trudeau Liberals added $123-million for the NRC to not only expand the Royalmount facility, but also build an entirely new production site beside it capable of pumping out two million doses of vaccine a month.

It won’t be able to produce the messenger RNA vaccines, like those from Pfizer-BioNTech and Moderna, but can make most other types of vaccines. Once the deal is finalized, Novavax will have to transfer its technology to the NRC, which can then begin scaling up production.

Canada invested another $173 million to Quebec’s Medicago to push research on its vaccine and build a new production plant in Quebec. If Medicago’s vaccine turns out to be safe and effective for COVID-19, it will initially be made in North Carolina.

Canada’s only vaccine production exists with Sanofi in Toronto and GlaxoSmithKline in Quebec. Sanofi pumps out millions of doses of vaccine in Toronto for diseases like whooping cough, polio and tetanus, while GSK’s Quebec plant is where Canada gets most of its annual flu vaccine.

The two are collaborating on a COVID-19 vaccine, which was delayed until at least the fall after initial results were not as good as hoped. But their plan, like that of Pfizer, Moderna, Novavax and Johnson and Johnson, does not involve making any of that vaccine in Canada.

Canada used to have a strong domestic vaccine industry. Federal records show in 1973, Canada relied on imports for only about one-fifth of its domestic pharmaceutical requirements including both vaccines and therapeutic drugs.

But the industry began to dry up in the 1980s, with multiple firms closing their Canadian operations, including AstraZeneca, Bristol Myers and Johnson and Johnson.

Today, Canada relies on imports for at least 85 per cent of the vaccines and other pharmaceuticals it uses.

Mia Rabson, The Canadian Press


Like us on Facebook and follow us on Twitter.

Want to support local journalism during the pandemic? Make a donation here.

Coronavirusvaccines

Get local stories you won't find anywhere else right to your inbox.
Sign up here

Just Posted

There were 31 new COVID-19 cases in the Terrace local health area during the week of Feb. 21 to Feb. 27, 2021. (BC Centre for Disease Control)
Northwest B.C. remains a COVID-19 hot spot

There were 31 new cases reported in the Terrace local health area between Feb. 21 and Feb. 27

Union of B.C. Indian Chiefs president and Grand Chief Stweart Phillip speaking at a rally with chiefs from around B.C. outside of the Coastal GasLink pipeline route in 2019. The UBCIC said in an open letter to Terrace city council that it was “heartbroken” to hear about the situation. (Black Press Media File Photo)
Union of B.C. Indian Chiefs ‘heartbroken’ by McCallum-Miller resignation

Terrace’s first Indigenous councillor resigned Feb. 22, alleging systemic racism

Terrace RCMP found gloves containing suspected methamphetamine and purple fentanyl following a traffic stop on the afternoon of March 2, 2021. (Black Press Media File Photo)
Terrace RCMP seize suspected methamphetamine, fentanyl following traffic stop

Police observed passenger of the vehicle trying to hide bags of white substance between their legs

General voting day for the Terrace trustee by-election is Saturday, March 6 at the Terrace Sportsplex Multipurpose Room from 8 a.m. to 8 p.m. (Black Press file photo)
Terrace trustee by-election: Meet the candidates

General voting day is March 6 at the Terrace Sportsplex Multipurpose Room from 8 a.m. to 8 p.m.

Terrace RCMP arrested two men on Feb. 17 after they were told to leave the Sunshine Inn and then became combative with police. (Black Press Media File Photo)
Terrace RCMP arrest men visiting a person in COVID-19 isolation

Men attempted to strike police with a chair, threatened to kill officers when told to leave

B.C. Health Minister Adrian Dix and provincial health officer Dr. Bonnie Henry head for the B.C. legislature press theatre to give a daily update on the COVID-19 pandemic, April 6, 2020. (B.C. government)
B.C. nears 300,000 COVID-19 vaccinations, essential workers next

564 new cases, four deaths, no new outbreaks Thursday

Municipal Affairs Minister Josie Osborne speaks in the B.C. legislature, March 4, 2021. (Hansard TV)
B.C. Liberals, NDP sing in harmony on local election reforms

Bill regulates paid canvassers, allows people in condo buildings

(National Emergency Management Agency)
No tsunami risk to B.C. from powerful New Zealand earthquake: officials

An 8.1 magnitude earthquake shook the north of New Zealand Thursday morning

(AP Photo/Richard Vogel, File)
Pandemic stress, isolation key factors as to why Canadians turned to cannabis, alcohol

Study found that isolation played key role in Canadians’ substance use

Grand Forks’ Gary Smith stands in front of his Church of the Flying Spaghetti Monster float. Photo: Submitted
Grand Forks’ Flying Spaghetti Monster leader still boiling over driver’s licence photo

Gary Smith, head of the Church of the Flying Spaghetti Monster of B.C., said he has since spoken to lawyers

A Cowichan Valley mom is wondering why masks haven’t been mandated for elementary schools. (Metro Creative photo)
B.C. mom frustrated by lack of mask mandate for elementary students

“Do we want to wait until we end up like Fraser Health?”

(Pxhere)
B.C. research reveals how pandemic has changed attitudes towards sex, health services

CDC survey shows that 35 per cent of people were worried about being judged

Some Canadians are finding butter harder than usual, resulting in an avalanche of social media controversy around #buttergate. (Brett Williams/The Observer)
#Buttergate: Concerns around hard butter hit small B.C. towns and beyond

Canadians find their butter was getting harder, blame palm oil in part one of this series

Most Read